London, May 1, 2026, 20:12 BST
BlackRock Portfolio Management LLC has revealed a 6.9% beneficial stake in Rentokil Initial plc, putting a new number on its ownership of the British pest-control firm as investors seek signs of a North American turnaround. According to a Schedule 13G/A, filed April 30, BlackRock holds beneficial ownership of 175,098,972 shares, including sole voting rights over 162,993,738. “Beneficial ownership” refers to voting or selling power, so not every share is held directly. SEC
Timing is key here: Rentokil’s annual meeting lands on May 7, less than a week away, and the company remains under the gun to deliver improved U.S. performance. In its most recent trading update, Rentokil posted first-quarter group revenue of $1.677 billion, with organic revenue growth—stripping out currency swings and most deals—coming in at 3.4%. North America contributed $995 million, showing 3.9% organic growth in the region.
Some of that turnaround is already reflected in the price. As London wrapped up for the day, delayed AJ Bell figures had Rentokil trading at 498.30 pence on the sell side and 498.90 pence to buy—just shy of the 507.00 pence high for the year. Market cap stood around 12.37 billion pounds.
The BlackRock filing doesn’t explicitly point to activist intentions. It certifies the shares are held in the ordinary course, not aimed at steering control at Rentokil. March 31 is listed as the event date, so this isn’t a same-day trade.
Chief Executive Mike Duffy described the first quarter as a “good start to the year,” emphasizing “continued momentum in North America.” Rentokil maintained its confidence in achieving full-year results that match market expectations, but flagged ongoing uncertainty tied to geopolitical events.
The numbers got messier beneath the surface. North America pest-control services posted 2.8% organic revenue growth. Business Services, on the other hand, climbed 12.7%. Customer retention landed at 80.4%, roughly matching 2025. Colleague retention edged higher, reaching 82.6%.
Analysts wasted little time targeting the soft underbelly. Suhasini Varanasi from Goldman Sachs questioned if gains in North American pest services had staying power. Morgan Stanley’s Annelies Vermeulen zeroed in on pricing and volumes. “Volumes are still negative,” replied CFO Paul Edgecliffe-Johnson, calling the surge in Business Services “an aberration rather than the norm.”
The competitive landscape keeps shifting. Rollins, a U.S. pest-control competitor, posted first-quarter revenue of $906 million—an increase of 10.2%. Organic revenue climbed 6.6%. CEO Jerry Gahlhoff called the start to the company’s peak season “strong.” PR Newswire
Still, risks remain. A passive 13G on the books doesn’t address customer churn, branch integration headaches, or the ongoing price-versus-volume dilemma. Edgecliffe-Johnson told Jefferies analyst Allen Wells that North American recurring revenue growth is coming from price hikes, as the group looks to move past the integration phase.
Shareholders are set to vote at the annual meeting on a proposed final dividend of 8.24 cents per ordinary share for 2025—equivalent to 6.10 pence. If the measure passes, payment is scheduled for May 18. The meeting lands amid a transition at the top: Thérèse Esperdy is slated to take over as chair Sept. 1, following her board appointment in July.
July 30 stands out as the next big test: that’s when Rentokil drops its interim results. Investors will be watching to see if improved U.S. sales execution is finally driving real volume gains—or if the stock’s momentum has outpaced what the numbers can actually support.
